期刊文献+

人体β-防御素-3突变基因的克隆及在大肠杆菌中的表达 被引量:1

Cloning of Site-directed Mutant of Human β-Defensin-3 Gene and Its Expression in E.coli
下载PDF
导出
摘要 目的对人体β-防御素-3基因进行定点突变,并在E.coli中表达。方法从人正常皮肤组织中提取总RNA,经RT-PCR扩增编码β-防御素-3成熟肽的cDNA,测序正确后,设计含突变位点的引物,用PCR重叠延伸法对β-防御素-3成熟肽cDNA进行定点突变,将突变产物克隆至pUC18,并在E.coli中融合表达。结果测序结果表明,经RT-PCR所得的β-防御素-3成熟肽序列与GenBank中报道的序列完全一致。经过突变,β-防御素-3成熟肽第29位谷氨酰胺密码子由CAG突变为精氨酸密码子CGA,其余核苷酸序列均未发生变化。将突变β-防御素-3基因在E.coli中诱导表达后,可见突变β-防御素-3蛋白表达。结论已成功克隆并表达了β-防御素-3突变体基因。 Objective To induce the site-directed mutation of human β-defensin-3 (hBD-3) gene and express the mutant in E. eoli. Methods Extract total RNA from normal human skin tissue, then amplify the eDNA encoding the mature peptide of β-defensin-3 by RT-PCR and identify by sequencing. Design a pair of primers containing mutation site and induce the site-directed mutation of the amplified eDNA by over-lap extension PCR. Clone the mutant into vector pUC18 and express in E. coll. Results The gene sequence of the amplified mature peptide of β-defensin-3 was completely consistent with that reported in GenBank. After site-directed mutation,the codon at site 29 of β-defensin-3 mature peptide changed from CAG encoding glutamine to CGA encoding arginine,however, no change of the rest nucleotide sequence was observed. The mutant of human β-defensin-3 was expressed in E. coll. Conclusion The site-directed mutant of human β-defensin-3 gene was successfully cloned and expressed.
出处 《中国生物制品学杂志》 CAS CSCD 2006年第1期34-37,共4页 Chinese Journal of Biologicals
基金 甘肃省自然科学基金资助项目(3ZS041-A25-055)
关键词 人体β-防御素-3 基因突变 基因克隆 测序 表达 Human β-defensin-3 Gene mutation Gene cloning Sequence Expression
  • 相关文献

参考文献8

  • 1查向东,徐康森,刘兢.阳离子抗菌肽研究进展[J].中国药理学通报,2003,19(7):735-740. 被引量:13
  • 2Ganz T,Lehrer RI.Defensins.Pharmacol Ther,1995,66 (2):191-205.
  • 3Harder J,Bartel J,Christophers E,et al.Isolation and characterization of human beta-defensin-3,a novel human inducible peptide antibiotic.Bio Chem,2001,276(8):5707-5713.
  • 4萨姆布鲁克J.拉塞尔DW.著.分子克隆实验指南.第3版.黄培堂等,译.北京:科学出版社,2002.27~30.
  • 5Fellermann K,Stange EF.Defensins-innate immunity at the epithelial frontier.Eur J Gastroenterol Hepatol,2001,13 (7):771-776.
  • 6Dinulos JG,Mentele L,Fredericks LP,et al.Keratinocyte expression of human beta defensin 2 following bacterial infection:role in cutaneous host defense.Clin Diagn Lab Immunol,2003,10 (1):161-166.
  • 7Schibli DJ,Hunter HN,Aseyev V,et al.The solution structures of the human β-defensin lead to a better understanding of the potent bactericidal activity of hBD3 against Staphylococues aureus.Bio Chem,2002,277 (10):8279-8289.
  • 8Hoover DM,Wu ZB,Tucker K,et al.Antimicrobial characterization of human β-defensin 3 derivatives.Ant Age and Chem,2003,47(9):2804-2809.

二级参考文献44

  • 1[1]Nilsson MF,Soandstedt B,Sorensen O et al. The human cationic antimicrobial protein (hCAP18),a peptide antibiotic,Is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infection and Immunity,1999;67(5):2561~6
  • 2[2]Zhao C,Nguyen T,Boo LM et al. RL-37,an alpha-helical antimicrobial peptide of the rhesus monkey. Antimicrobial Agents and Chemotherapy,2001;45(10):2695~702
  • 3[3]Patrzykat A,Zhang L,Mendoza V et al. Synergy of histone-derived peptides of coho salmon with lysozyme and flounder pleurocidin. Antimicrobial Agents and Chemotherapy, 2001;45(5):1337~42
  • 4[4]Hancock REW,Scott MG. The role of antimicrobial peptides in animal defenses. Proc. Natl Acad Sci USA, 2000;97(16):8856~61
  • 5[5]Nagpal S,Kaur KJ,Jain D,Salunke DM. Plasticity in structure and interactions is critical for the action of indolicidin,an antibacterial peptide of innate immune origin. Protein Sci,2002;11(9):2158~67
  • 6[6]Hase K,Eckmann L, Leopard JD et al. Cell differentiation is a key determinant of cathelicidin LL-37/Human cationic antimicrobial protein 18 expression by human colon epithelium. Infection and Immunity, 2002;70(2):953~1063
  • 7[7]Cole AM,Darouiche RO,Legarda D et al. Characterization of a fish antimicrobial peptide: Gene expression,subcellular localization,and spectrum of activity. Antimicrobial Agents and Chemotherapy, 2000;44(8):2039~45
  • 8[8]Diamond G,Kaiser V,Rhodes J et al. Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells. Infect Immun,2000;68(1):113~9
  • 9[9]Kwon SY,Carlson BA,Park JM,Lee BJ. Structural organization and expression of the gaegurin 4 gene of Rana rugosa. Biochim Biophys Acta,2000;1492(1):185~90
  • 10[10]Giacometti A,Cirioni O,Barchiesi F et al. In vitro activity of polycationic peptides against cryptosporidium parvum,pneumocystis carinii and yeast clinical isolates. J Antimicrob Chemother,1999;44(3):403~6

共引文献14

同被引文献11

  • 1任明华,王淑静,林雪松,徐建永,陶站华,赵炜明,刘兴汉.重组人内皮抑素的结构改造及抗肿瘤活性变化[J].中国生物化学与分子生物学报,2005,21(1):45-52. 被引量:17
  • 2Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature, 1997, 390(6658 ): 404-407.
  • 3Neskey DM, Ambesi A, Pumiglia KM, et al. Endostatin and anastellin inhibit distinct aspects of the angiogenic process. J Exp Clin Cancer Res, 2008, 27( 1 ): 61.
  • 4Dhanabal M, Volk R, Ramchandran R, et al. Cloning, expression, and in vitro activity of human endostatin. Biochem Biophys Res Commun, 1999, 258(2): 345-352.
  • 5Chura-Chambi R, Tornieri PH. Spencer PJ, et al. High-level synthesis of recombinant murine endostatin in Chinese hamster ovary cells. Protein Expr Purif, 2004, 35( 1 ): 11-16.
  • 6Su Z, Wu X, Feng Y, et al. High level expression of human endostatin in Pichia pastoris using a synthetic gene construct. Appl Microbiol Biotechnol, 2007, 73(6): 1355-1362.
  • 7Xu HM, Zhang GY, Ji XD, et al. Expression of soluble, biologically active recombinant human endostatin in Escherichia coli. Protein Expr Purif, 2005, 41(2): 252-258.
  • 8Cattaneo MG, Pola S, Francescato P, et al. Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo. Exp Cell Res, 2003, 283(2): 230-236.
  • 9Ding YH, Javaherian K, Lo KM, et al. Zinc-dependent dimers observed in crystals of human endostatin. Proc Natl Acad Sci USA, 1998, 95( 18): 10443-10448.
  • 10Sasaki T, Larsson H, Kreuger J, et al. Structural basis and potential role of heparin / heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J, 1999, 18(22): 6240-6248.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部